Items where Author is "Hernandez, Inmaculada"

Item Type No Grouping

Article

Drug prices negotiated by medicare vs US net prices and prices in other countries. (2024) Wouters, Olivier J.; Sullivan, Sean D.; Cousin, Emma M.; Gabriel, Nico; Papanicolas, Irene; Hernandez, Inmaculada picture_as_pdf

Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025. (2024) Cousin, Emma M.; Sullivan, Sean D.; Hansen, Ryan N.; Gabriel, Nico; Kirihennedige, Ayuri S.; Hernandez, Inmaculada

Medicare drug price negotiation:the complexities of selecting therapeutic alternatives for estimating comparative effectiveness. (2024) Hernandez, Inmaculada; Cousin, Emma; Wouters, Olivier J.; Gabriel, Nico; Cameron, Teresa; Sullivan, Sean D. picture_as_pdf

Net prices of new antiobesity medications. (2024) Hernandez, Inmaculada; Sullivan, Sean D.

Has the Centers for Medicare & Medicaid Services implicitly adopted a value framework for Medicare drug price negotiations? (2023) Sullivan, Sean D.; Hernandez, Inmaculada; Ramsey, Scott D.; Neumann, Peter J.

Association of research and development investments with treatment costs for new drugs approved from 2009 to 2018. Wouters, Olivier J.; Berenbrok, Lucas A.; He, Meiqi; Li, Yihan; Hernandez, Inmaculada picture_as_pdf

Integrating price benchmarks and comparative clinical effectiveness to inform the medicare drug price negotiation program. Sullivan, Sean D.; Wouters, Olivier J.; Cousin, Emma M.; Kirihennedige, Ayuri S.; Hernandez, Inmaculada picture_as_pdf

Price benchmarks of drugs selected for medicare price negotiation and their therapeutic alternatives. Hernandez, Inmaculada; Cousin, Emma M.; Wouters, Olivier J.; Gabriel, Nico; Cameron, Teresa; Sullivan, Sean D. picture_as_pdf